Related Experiment Videos
Fibrinogen fragments and platelet dysfunction in uremia
S A Kozek-Langenecker1, T Masaki, H Mohammad
1Department of Anesthesiology, University of Vienna, Austria.
Kidney International
|July 20, 1999
Summary
Fibrinogen fragments in uremic plasma impair platelet function by blocking fibrinogen receptors, leading to reduced platelet aggregation. This explains a key aspect of uremic platelet dysfunction.
Area of Science:
- Hematology
- Biochemistry
- Pathophysiology
Background:
- Uremia is associated with impaired platelet aggregation.
- Fibrinogen fragments, present in uremic plasma, are implicated in this dysfunction.
Purpose of the Study:
- Investigate the role of fibrinogen fragments in uremic platelet dysfunction.
- Examine fibrinogen receptor (GP IIb-IIIa) availability and function.
Main Methods:
- Flow cytometry to assess GP IIb-IIIa availability using specific antibodies.
- Assessed receptor function via fibrinogen binding and platelet aggregation assays.
- Studied the effect of fibrinogen fragments on normal platelets.
Main Results:
- Uremic patients showed lower platelet aggregation and GP IIb-IIIa availability.
- Fibrinogen fragments reduced antibody binding to GP IIb-IIIa on resting and activated platelets.
- Fibrinogen fragments decreased fibrinogen binding and ADP-induced aggregation in normal platelets.
Conclusions:
- Fibrinogen fragments impair platelet function by blocking GP IIb-IIIa receptors before activation.
- This mechanism explains how uremic plasma fragments contribute to platelet dysfunction.